Write a reviewFor vendors
♡
Home / Investors / Startups / Kyverna Therapeutics

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
kyvernatx.com ↗LinkedIn

About Kyverna Therapeutics

KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Their therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

Industries

BioTechLife ScienceHealthcare

Investors in Kyverna Therapeutics (5)

Insight Partners

Venture Fund · New York · Founded 1995
Pre-SeedSeedSeries ASeries BArtificial Intelligence & Machine Learning (AI/ML)FinTechBig Data & AnalyticsCloudTech+12
910Investments
185Exits

LYFE Capital

Venture Fund · Shanghai, China · Founded 2014
SeedSeries ASeries BBioTechLife ScienceHealthcareMedical Device
43Investments
5Exits

Gilead Sciences

Corporate VC · Foster City · Founded 1987
Series CSeries DSeries BBioTechLife ScienceHealthcareMedical Device+5
29Investments
10Exits

CAM Capital

Venture Fund · New York · Founded 2012
BioTechHealthcareLife Science
25Investments
11Exits

Intellia Therapeutics

Cambridge, Massachusetts · Founded 2014
BioTechLife ScienceHealthcare
2Investments
—Exits